Ocrevus (brand name or ocrelizumab, drug name) is a new drug treatment for MS which has received a license in UK for RRMS but not PPMS (which it has been shown to be effective at treating). Read about it here:

https://www.mssociety.org.uk/ms-research/treatments-in-the-pipeline/ocrelizumab 

Hullabaloo
3,958
Status
Approved
Share